Literature DB >> 101135

In vitro comparison of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa.

A G Paradelis, J Douboyas, G Stathopoulos, A Grigoriadou-Edipides, C Triantaphylidis, J Papapanagiotou.   

Abstract

The antimicrobial activity of kanamycin, kanendomycin, gentamicin, amikacin, sisomicin, and dibekacin against 200 strains of Pseudomonas aeruginosa was compared. Dibekacin was found to be the most active against the tested organisms, whereas the other aminoglycoside antibiotics fell in the following order of diminishing antibacterial potency: amikacin, sisomicin, gentamicin, kanendomycin, and kanamycin. Seven strains showed high-level resistance to gentamicin (minimal inhibitory concentration, 400 mug/ml), and two of them were also resistant to amikacin and sisomicin (minimal inhibitory concentration, 75 mug/ml). The minimal inhibitory concentration of dibekacin for these seven strains was 0.625 mug/ml.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 101135      PMCID: PMC352495          DOI: 10.1128/AAC.14.3.514

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  1 in total

1.  3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa.

Authors:  H Umezawa; S Umezawa; T Tsuchiya; Y Okazaki
Journal:  J Antibiot (Tokyo)       Date:  1971-07       Impact factor: 2.649

  1 in total
  6 in total

1.  Neuromuscular blocking activity of dibekacin, a new semisynthetic aminoglycoside antibiotic.

Authors:  A G Paradelis; J S Tsouras; P Latsoudes; T Demetriou; C Triantaphyllidis
Journal:  Experientia       Date:  1980-07-15

2.  In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.

Authors:  L Pulliam; W K Hadley; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

Review 3.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

4.  In vitro comparison of aminoglycoside activities and their synergistic action with piperacillin.

Authors:  J A Hoogkamp-Korstanje
Journal:  Infection       Date:  1985 Jan-Feb       Impact factor: 3.553

5.  In vitro comparison of dibekacin and gentamicin activities.

Authors:  C D Hill; G W Counts; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Comparative nephrotoxicities of dibekacin, amikacin, and gentamicin in a rat model.

Authors:  L I Rankin; F C Luft; M N Yum; L L Isaacs
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.